Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
about
Curcumin and diabetes: a systematic reviewThe role of epigenetics in the pathology of diabetic complicationsHuman genetics of diabetic vascular complicationsCardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapiesDiabetic cardiomyopathy: where we are and where we are going.Impact of glycemic control on aortic stiffness, left ventricular mass and diastolic longitudinal function in type 2 diabetes mellitusImpairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin.Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesMicroRNAs in β-cell biology, insulin resistance, diabetes and its complicationsEpigenetic mechanisms in diabetic complications and metabolic memory.Garlic Oil Alleviates MAPKs- and IL-6-mediated Diabetes-related Cardiac Hypertrophy in STZ-induced DM RatsMicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy.miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetesAcetylation of myocardin is required for the activation of cardiac and smooth muscle genes.Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker.Signaling mechanisms of a water soluble curcumin derivative in experimental type 1 diabetes with cardiomyopathy.Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic miceDiabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management.Oxidative stress: a key contributor to diabetic cardiomyopathy.Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.Oxidative-stress-induced epigenetic changes in chronic diabetic complications.Human genetics of diabetic retinopathy.Human genetics of diabetic nephropathy.Tropisetron inhibits high glucose-induced calcineurin/NFAT hypertrophic pathway in H9c2 myocardial cells.microRNA profiling in atherosclerosis, diabetes, and migraine.High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy.Cardioprotective role of Syzygium cumini against glucose-induced oxidative stress in H9C2 cardiac myocytes.Curcumin: a potential therapeutic polyphenol, prevents noradrenaline-induced hypertrophy in rat cardiac myocytes.MicroRNAs in diabetic cardiomyopathy and clinical perspectives.Curcumin ameliorates streptozotocin-induced heart injury in rats.Dimethylthiourea normalizes velocity-dependent, but not force-dependent, index of ventricular performance in diabetic rats: role of myosin heavy chain isozyme.High glucose augments angiotensinogen in human renal proximal tubular cells through hepatocyte nuclear factor-5.Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy.Hyperoxia-induced cardiotoxicity and ventricular remodeling in type-II diabetes mice.Morphological restructuring of myocardium during the early phase of experimental diabetes mellitus.Aging-associated changes in hippocampal glycogen metabolism in mice. Evidence for and against astrocyte-to-neuron lactate shuttle.Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control
P2860
Q21284809-DC9DF30C-590F-4603-919D-2CA6C8F0BBC3Q24609124-BC22EB4D-A996-417A-A61F-4C27E09B92D1Q27000709-D26C92AB-4DA7-4C3E-A04C-EADCBB6185C5Q27002459-8C2C3CBD-B62C-402A-A8CB-A8AFD106DE2CQ33690717-27B26E01-DFF3-4100-A075-885C2D3FB7F4Q33808313-47596708-F626-43C3-9E02-0ECF8DA57AA4Q34093212-0AA26689-C1A3-4744-BBE5-D4F4D1E226DBQ34594807-335786CF-DEF0-4B72-907E-97CF797E1F66Q35063263-B2420B42-4CC3-45EF-B552-E114EBE57BC8Q35071700-30BB682B-B66C-4A54-BCFE-E69C4DFE6992Q35109612-26AFDE9C-0E8D-4BDE-BFEE-1D2D726BF336Q35167928-37F958F2-7C8D-4D11-94A3-C8595EDA41CCQ36310864-25E8F128-DE55-4E2D-AFDF-EE336C51A592Q36385770-348D19B9-4051-44F3-892E-4CFA856BB10CQ36690425-E0DD1F4D-4DF8-4ECC-904D-78C124E58905Q36698572-36411BB5-A579-4C73-9788-E44EE5BD4221Q37018537-E19A5C6B-D395-4E62-A6F4-9B968F10053EQ37232675-999AECA5-8DFC-46EA-B658-2559902A9659Q37731339-C2CC61FD-C6D2-45FC-84FB-5ED5906803E6Q38083574-859BF31F-BC27-4E9F-B3F7-63E1B43186FAQ38093867-FE4E8A23-8C65-4AE9-A52A-2A27EB07D3D2Q38247113-FD607269-C3A5-4D17-818F-4FFCAD17C0A5Q38320756-291A66DC-D25E-4F2C-BBBD-1400E3F71DCDQ38788707-0BC31EB1-3B27-4F37-8362-4683DD458388Q38827929-A982983E-157D-48C8-B846-FC17559966C7Q38989355-D0624B66-7F65-4B1C-B5CE-87509F9FCA86Q39178300-A9CCB07E-CB4A-439F-BE9D-EA225AD884E5Q39446989-AEA6E918-C40F-4132-A728-5577A26B629EQ41147182-9E7C2C91-CDA1-45F1-940E-15DC0A3EC4DBQ42705885-3B36F07D-60FF-4C69-9285-C828BA01968AQ45919528-6B1291A8-637F-4BA6-8C04-9205FF2B65B8Q47137843-27233C24-725E-46EF-AFC9-5748D5B65463Q48487014-849E8E80-605F-4C51-98F3-2C8BDBA1F1B7Q50055567-3E96CF5C-FF10-428C-BDB6-F0E3650E47EFQ50459619-44A79677-6736-4BE4-A4E0-43A98B8AECF8Q50533604-D5FAEA39-F4A6-4A49-9912-88C9A0FB16DCQ58698076-55369AD0-920E-4234-BD65-7658FA359610
P2860
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
description
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
scientific journal article
@en
vedecký článok (publikovaný 2008/06/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/06/01)
@nl
наукова стаття, опублікована в червні 2008
@uk
مقالة علمية (نشرت في يونيو 2008)
@ar
name
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
@ast
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
@en
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
@nl
type
label
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
@ast
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
@en
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
@nl
prefLabel
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
@ast
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
@en
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
@nl
P2093
P2860
P1476
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level
@en
P2093
Biju George
Shali Chen
P2860
P304
P356
10.1152/AJPENDO.00029.2008
P577
2008-04-15T00:00:00Z